Towbin Jeffrey A, Lowe April M, Colan Steven D, Sleeper Lynn A, Orav E John, Clunie Sarah, Messere Jane, Cox Gerald F, Lurie Paul R, Hsu Daphne, Canter Charles, Wilkinson James D, Lipshultz Steven E
Texas Children's Hospital, Baylor College of Medicine, Houston, USA.
JAMA. 2006 Oct 18;296(15):1867-76. doi: 10.1001/jama.296.15.1867.
Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and cause of cardiac transplantation in children. However, the epidemiology and clinical course of DCM in children are not well established.
To provide a detailed description of the incidence, causes, outcomes, and related risk factors for DCM in children.
Longitudinal study based on a population-based, prospective cohort of children diagnosed as having DCM since January 1, 1996, at 89 pediatric cardiac centers and a retrospectively collected cohort of patients seen primarily at large tertiary care centers in North America and who had diagnoses between January 1, 1990, and December 31, 1995, and were enrolled through February 2003.
A total of 1426 children from the United States and Canada diagnosed as having DCM at younger than 18 years. Primary DCM was determined by strict echocardiographic and/or pathologic criteria. Patients with disease due to endocrine, immunologic, drug toxicity, and other causes were excluded.
Annual incidence per 100,000 children; mortality; cardiac transplantation.
The annual incidence of DCM in children younger than 18 years was 0.57 cases per 100,000 per year overall. The annual incidence was higher in boys than in girls (0.66 vs 0.47 cases per 100,000; P<.001), in blacks than in whites (0.98 vs 0.46 cases per 100,000; P<.001), and in infants (<1 year) than in children (4.40 vs 0.34 cases per 100,000; P<.001). The majority of children (66%) had idiopathic disease. The most common known causes were myocarditis (46%) and neuromuscular disease (26%). The 1- and 5-year rates of death or transplantation were 31% and 46%, respectively. Independent risk factors at DCM diagnosis for subsequent death or transplantation were older age, congestive heart failure, lower left ventricular fractional shortening Z score, and cause of DCM (P<.001 for all).
In children, DCM is a diverse disorder with outcomes that depend largely on cause, age, and heart failure status at presentation. Race, sex, and age affect the incidence of disease. Most children do not have a known cause of DCM, which limits the potential for disease-specific therapies.
扩张型心肌病(DCM)是儿童心肌病最常见的形式,也是儿童心脏移植的主要原因。然而,儿童DCM的流行病学和临床病程尚未完全明确。
详细描述儿童DCM的发病率、病因、转归及相关危险因素。
本研究为纵向研究,基于1996年1月1日起在89个儿科心脏中心确诊为DCM的儿童的基于人群的前瞻性队列,以及回顾性收集的主要来自北美大型三级医疗中心、在1990年1月1日至1995年12月31日期间确诊且截至2003年2月入组的患者队列。
共有来自美国和加拿大的1426名18岁以下被诊断为DCM的儿童。原发性DCM通过严格的超声心动图和/或病理标准确定。排除由内分泌、免疫、药物毒性及其他原因导致疾病的患者。
每10万名儿童的年发病率;死亡率;心脏移植情况。
18岁以下儿童DCM的总体年发病率为每10万人每年0.57例。男孩的年发病率高于女孩(每10万人0.66例对0.47例;P<0.001),黑人高于白人(每10万人0.98例对0.46例;P<0.001),婴儿(<1岁)高于儿童(每10万人4.40例对0.34例;P<0.001)。大多数儿童(66%)患有特发性疾病。最常见的已知病因是心肌炎(46%)和神经肌肉疾病(26%)。1年和5年的死亡或移植率分别为31%和46%。DCM诊断时随后发生死亡或移植的独立危险因素为年龄较大、充血性心力衰竭、左心室缩短分数Z值较低以及DCM的病因(所有P<0.001)。
在儿童中,DCM是一种多样的疾病,其转归很大程度上取决于病因、年龄及就诊时的心力衰竭状态。种族、性别和年龄影响疾病的发病率。大多数儿童DCM的病因不明,这限制了针对疾病特异性治疗的可能性。